Перевести на Переведено сервисом «Яндекс.Перевод»

Endocyte

Country
USA
Краткое название
Endocyte
Headquarters
3000 Kent Avenue Suite A1-100
Members of the board

P. Ron Ellis,
CEO / President
Mike A. Sherman,
Chief Financial Officer
Philip S. Low Ph.D,
Chief Science Officer
David Meek,
Chief Commercial Officer
Christopher P. Leamon Ph.D,
Vice President of Research & Development
Chandra D. Lovejoy,
Vice President of Regulatory Affairs
Binh Nguyen M.D., Ph.D.,
Vice President of Clinical Affairs
Allen R. Ritter Ph.D,
Vice President of Manufacturing / CMC
Iontcho Vlahov Ph.D,
Vice President of Discovery Chemistry
Matthew Call,
Vice President of Business Development

Categories medicine
Oncology, Infectious diseases
Stage of the project
Production
Disease
Influenza, Lung cancer
Ticker
ECYT
Current owners

John C. Aplin,
Chairman
P. Ron Ellis,
CEO / President
Philip S. Low Ph.D,
Chief Science Officer
Douglas G. Bailey,
President & CEO
American Bailey Corporation
Fred A. Middleton,
General Partner
Sanderling Venture Partners,
Ann F. Hanham Ph.D.
Managing Director
Burrill & Company
Keith E. Brauer,
Former VP Finance / CFO
Guidant Corporation
Peter D. Meldrum Ph.D.,
President & CEO
Myriad Genetics, Inc.
Marc Kozin,
Senior Advisor
L.E.K. Consulting
Lesley Russell M.B.Ch.B, MRCP,
Former Senior Vice President
Teva Pharmaceuticals

Assets
228.9300
Technology
Cell Technologies, Services, Technologies, Pharmaceuticals, Chemistry